Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Perispinal etanercept: potential as an Alzheimer therapeutic.

Griffin WS.

J Neuroinflammation. 2008 Jan 10;5:3. doi: 10.1186/1742-2094-5-3.

2.

Perispinal etanercept for treatment of Alzheimer's disease.

Tobinick E.

Curr Alzheimer Res. 2007 Dec;4(5):550-2. Review.

PMID:
18220520
3.

Tumour necrosis factor modulation for treatment of Alzheimer's disease: rationale and current evidence.

Tobinick E.

CNS Drugs. 2009 Sep;23(9):713-25. doi: 10.2165/11310810-000000000-00000. Review.

PMID:
19689163
4.
5.

Perispinal etanercept for neuroinflammatory disorders.

Tobinick E.

Drug Discov Today. 2009 Feb;14(3-4):168-77. doi: 10.1016/j.drudis.2008.10.005. Epub 2008 Dec 6. Review.

PMID:
19027875
6.

Perispinal etanercept: a new therapeutic paradigm in neurology.

Tobinick E.

Expert Rev Neurother. 2010 Jun;10(6):985-1002. doi: 10.1586/ern.10.52. Review. Erratum in: Expert Rev Neurother. 2010 Jul;10(7):1232.

PMID:
20518613
7.

Down-titration and discontinuation strategies of tumor necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease activity.

van Herwaarden N, den Broeder AA, Jacobs W, van der Maas A, Bijlsma JW, van Vollenhoven RF, van den Bemt BJ.

Cochrane Database Syst Rev. 2014 Sep 29;(9):CD010455. doi: 10.1002/14651858.CD010455.pub2. Review.

PMID:
25264908
8.

Etanercept, a novel drug for the treatment of patients with severe, active rheumatoid arthritis.

Goldenberg MM.

Clin Ther. 1999 Jan;21(1):75-87; discussion 1-2. Review.

PMID:
10090426
9.

Use of etanercept in the treatment of psoriasis and psoriatic arthritis.

Fuchs BS, Hadi S.

Rev Recent Clin Trials. 2006 Sep;1(3):259-63. Review.

PMID:
18473978
10.

Etanercept: a review of its use in rheumatoid arthritis.

Jarvis B, Faulds D.

Drugs. 1999 Jun;57(6):945-66. Review.

PMID:
10400407
11.

[Etanercept].

Sparsa A.

Ann Dermatol Venereol. 2005 Nov;132(11 Pt 1):861-76. Review. French.

PMID:
16327716
12.

Etanercept: a review of its use in autoimmune inflammatory diseases.

Scott LJ.

Drugs. 2014 Aug;74(12):1379-410. doi: 10.1007/s40265-014-0258-9. Review.

PMID:
25034360
13.

Etanercept: therapeutic use in patients with rheumatoid arthritis.

Garrison L, McDonnell ND.

Ann Rheum Dis. 1999 Nov;58 Suppl 1:I65-9. Review.

14.

Etanercept for the treatment of rheumatoid arthritis.

Lethaby A, Lopez-Olivo MA, Maxwell L, Burls A, Tugwell P, Wells GA.

Cochrane Database Syst Rev. 2013 May 31;(5):CD004525. doi: 10.1002/14651858.CD004525.pub2. Review.

PMID:
23728649
15.

Safety and efficacy of disease-modifying anti-rheumatic agents: focus on the benefits and risks of etanercept.

Fleischmann R, Iqbal I, Nandeshwar P, Quiceno A.

Drug Saf. 2002;25(3):173-97. Review.

PMID:
11945114
16.

Efficacy and safety of etanercept in chronic immune-mediated disease.

Murdaca G, Spanò F, Contatore M, Guastalla A, Magnani O, Puppo F.

Expert Opin Drug Saf. 2014 May;13(5):649-61. doi: 10.1517/14740338.2014.899579. Epub 2014 Mar 22. Review.

PMID:
24654562
17.

Etanercept Immunex.

Yung RL.

Curr Opin Investig Drugs. 2001 Feb;2(2):216-21. Review.

PMID:
11816834
18.

Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.

Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.

Health Technol Assess. 2006 Sep;10(31):iii-iv, xiii-xvi, 1-239. Review.

19.

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation.

McLeod C, Bagust A, Boland A, Dagenais P, Dickson R, Dundar Y, Hill RA, Jones A, Mujica Mota R, Walley T.

Health Technol Assess. 2007 Aug;11(28):1-158, iii-iv. Review.

20.

Etanercept for the treatment of psoriasis and psoriatic arthritis.

Gottlieb AB.

Dermatol Ther. 2004;17(5):401-8. Review.

PMID:
15379775

Supplemental Content

Support Center